The National Cancer Institute (NCI) invites National Clinical Trials Network (NCTN) Groups and NCI Community Oncology Research Program (NCORP) Research Bases to apply for funding to support biomarker, imaging, and symptom science/quality of life (symptom science/QOL) studies. All studies must be associated with NCI clinical trial concepts or protocols.
Studies must be associated with the following types of trials conducted by NCTN Groups or NCORP Research Bases and reviewed by the NCI Steering Committees:
- Randomized phase 2 or phase 3 treatment trials
- Randomized phase 2 or phase 3 prevention trials
- Randomized symptom science/supportive care clinical trials
- Non-randomized phase 2 or phase 3 treatment trials (integral studies only)
NCTN Program Note:
- If a BIQSFP proposal is being submitted in connection with an NCTN trials that is/was conducted under a CTEP Binding Collaborative Agreement and that proposal is selected for funding, please note that the CTEP company collaborator for that trial will need to review/comment and/or approve the proposal, depending on the trial's status.
- Such proposals if selected for funding will have a status of "Approval on Hold" until the company has reviewed it.
Resources Available to Assist You with Preparation of BIQSFP Application Package
- BIQSFP Guidelines (PDF)
- FAQs
- BIQSFP Checklists - Applicants should use the Checklists to complete the BIQSFP application.
- Budget/Budget Justification
- Evaluator Resources - Reviewer responsibilities consist of evaluating the proposed study and completing the evaluation templates with written comments by filling out the fields that follow each review criterion. This page contains the evaluation templates.
- Contacts